LABNEW fluctuates 21.4% in 24 hours: slight pullback after whale accumulation driven rebound
Bitget Pulse2026/05/17 16:02Brief Overview of Price Fluctuations
Over the past 24 hours, LABNEW (LAB) surged rapidly from a low of $4.4559 to a high of $5.40741, before falling back to the current $4.85445, with a price amplitude of 21.4%. The price exhibited a typical "V-shaped" rebound followed by a pressured correction, overall remaining in a high volatility range.
Summary of Reasons for Price Movements
- Whale address accumulation driving major rebound: On-chain monitoring shows multiple new wallets withdrawing large amounts from exchanges (previous similar operations involved about 100 million LAB, accounting for roughly 30% of the circulating supply), with average cost ranges near $4.9, directly supporting price rebounds from lows.
- Trading volume surge accompanied by net capital inflow: 24-hour trading volume stayed at high levels (with recent comparable volatility ranges spanning tens of millions to hundreds of millions USD). On-chain data indicates net capital inflow, increasing price elasticity.
- Natural corrections following significant prior distribution: In mid-May, 10 new wallets withdrew about 100 million LAB (worth over $480 million) from Bitget, an operation still remembered in the market. Some funds face profit-taking or distribution pressure, leading to a decline after reaching highs.
Market Perspectives and Outlook
The community and mainstream analysts remain cautiously optimistic regarding this price movement, believing whale accumulation offers short-term support, though high volatility raises concerns about manipulation. Some viewpoints highlight that without new positive catalysts, prices may test support near $4; analysts also warn of short-term profit-taking risk, recommending attention to large on-chain transfers and net outflows from exchanges to gauge the trend's sustainability.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is provided for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.